Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

226 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical drug development: an analysis of phase II trials, 1970-1985.
Marsoni S, Hoth D, Simon R, Leyland-Jones B, De Rosa M, Wittes RE. Marsoni S, et al. Cancer Treat Rep. 1987 Jan;71(1):71-80. Cancer Treat Rep. 1987. PMID: 3791270
Phase I study of elliptinium (2-N-methyl-9-hydroxyellipticinium).
Einzig AI, Gralla RJ, Leyland-Jones BR, Kelsen DP, Cibas I, Lewis E, Greenberg E. Einzig AI, et al. Cancer Invest. 1985;3(3):235-41. doi: 10.3109/07357908509039784. Cancer Invest. 1985. PMID: 4005651
Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II).
Kelsen DP, Scher H, Alcock N, Leyland-Jones B, Donner A, Williams L, Greene G, Burchenal JH, Tan C, Philips FS, Young CW. Kelsen DP, et al. Cancer Res. 1982 Nov;42(11):4831-5. Cancer Res. 1982. PMID: 7127319
Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer.
Berman E, Wittes RE, Leyland-Jones B, Casper ES, Gralla RJ, Howard J, Williams L, Baratz R, Young CW. Berman E, et al. Cancer Res. 1983 Dec;43(12 Pt 1):6096-101. Cancer Res. 1983. PMID: 6580068
2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug.
O'Dwyer PJ, Wagner B, Leyland-Jones B, Wittes RE, Cheson BD, Hoth DF. O'Dwyer PJ, et al. Ann Intern Med. 1988 May;108(5):733-43. doi: 10.7326/0003-4819-108-5-733. Ann Intern Med. 1988. PMID: 3282467 Review.
Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia.
Daghestani AN, Arlin ZA, Leyland-Jones B, Gee TS, Kempin SJ, Mertelsmann R, Budman D, Schulman P, Baratz R, Williams L, et al. Daghestani AN, et al. Cancer Res. 1985 Mar;45(3):1408-12. Cancer Res. 1985. PMID: 3855696
4-Ipomeanol: a novel investigational new drug for lung cancer.
Christian MC, Wittes RE, Leyland-Jones B, McLemore TL, Smith AC, Grieshaber CK, Chabner BA, Boyd MR. Christian MC, et al. J Natl Cancer Inst. 1989 Aug 2;81(15):1133-43. doi: 10.1093/jnci/81.15.1133. J Natl Cancer Inst. 1989. PMID: 2664191 Review.
Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid.
Grem JL, Hoth DF, Hamilton JM, King SA, Leyland-Jones B. Grem JL, et al. Cancer Treat Rep. 1987 Dec;71(12):1249-64. Cancer Treat Rep. 1987. PMID: 3319136 Review. No abstract available.
Gallium nitrate: the second metal with clinical activity.
Foster BJ, Clagett-Carr K, Hoth D, Leyland-Jones B. Foster BJ, et al. Cancer Treat Rep. 1986 Nov;70(11):1311-9. Cancer Treat Rep. 1986. PMID: 3533251 Review.
The application of a two-stage design for clinical trials in patients with recurrent head and neck cancer.
Eisenberger MA, Ellenberg S, Leyland-Jones B, Friedman M. Eisenberger MA, et al. Med Pediatr Oncol. 1988;16(3):162-8. doi: 10.1002/mpo.2950160303. Med Pediatr Oncol. 1988. PMID: 3288853 Review.
226 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback